COMPANY OVERVIEW
-
Main Products
Drug impurity reference,Impurity reference,Reference substance,impurity
-
Payment Terms
TT against copy of documents,100% TT in advance
-
Average lead Time
Peak season lead time: within 150 Workday
Off season lead time: within 70 Workday
-
Business Type
Manufactory -
Location
Hubei, China -
Year Established
2023 -
Total Employees
51-100 -
Total Annual Revenue
$5 million-$10 million
HOT PRODUCTS
-
(((R)-12-((S)-7,8-difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-yl)-6,8-dioxo-3,4,6,8,12,12a-hexahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazi
Get Price
INQUIRY -
Upadacitinib Impurity 1((3S,4S)-benzyl 3-(2-bromoacetyl)-4-ethylpyrrolidine-1-carboxylate)
Get Price
INQUIRY -
Upadacitinib Impurity 21-- (3R,4S)-benzyl 3-(2-chloroacetyl)-4-ethylpyrrolidine-1-carboxylate
Get Price
INQUIRY -
Rosuvastatin Impurity 38-N-(4-(4-fluorophenyl)-5-((E)-2-((2S,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl)vinyl)-6-isopropylpyrimidin-2-yl)methanesulfo
Get Price
INQUIRY -
(R)-7-(benzyloxy)-12-((R)-7,8-difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-yl)-3,4,12,12a-tetrahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine
Get Price
INQUIRY -
Probucol USP Related Compound C-- 2,6-di-tert-butyl-4-((2-((3,5-di-tert-butyl-2-hydroxyphenyl)thio)propan-2-yl)thio)phenol
Get Price
INQUIRY
Main Categories
-
Pharmaceutical Impurities Reference Standards
(43)
LATEST PRODUCTS
-
(((R)-12-((S)-7,8-difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-yl)-6,8-dioxo-3,4,6,8,12,12a-hexahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazi
Get PriceINQUIRY -
Upadacitinib Impurity 1((3S,4S)-benzyl 3-(2-bromoacetyl)-4-ethylpyrrolidine-1-carboxylate)
Get PriceINQUIRY -
Upadacitinib Impurity 21-- (3R,4S)-benzyl 3-(2-chloroacetyl)-4-ethylpyrrolidine-1-carboxylate
Get PriceINQUIRY -
Rosuvastatin Impurity 38-N-(4-(4-fluorophenyl)-5-((E)-2-((2S,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl)vinyl)-6-isopropylpyrimidin-2-yl)methanesulfo
Get PriceINQUIRY
Send an Inquiry
Brand certification certificate